Comparison of Subconjunctival 5-Fluorouracil (FU) Injection and Mitomycin C for Treatment of Early Bleb Failure
NCT00644215 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2008-06-17
Summary
purpose : to evaluate and compare the effectiveness and complication of 5-FU injections and MMC drop in management of early bleb failure .
Design:Randomized clinical trial Methods:Patients with low injected bleb in first month after filtering or combined surgery with MMC which don't respond to high frequent topical steroids and removal of releasable sutures will be randomize to either 5-FU injection or Mitomycin drop 0.02%.For each patient slit photograph in first day of recruiting,first two weeks and first and third month will be obtained.Patients will follow for at least 3 months and IOP ,bleb configuration will check as primary outcome measures.Preoperative and postoperative data,complications,and the need for further surgical procedures will be evaluated.
Conditions
- Bleb
Interventions
- DRUG
-
5-FU and Mitomycin
* 5-FU injection 5mg * Mitomycin drop 0.02%
Sponsors & Collaborators
-
Shahid Beheshti University of Medical Sciences
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 8 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2009-02-28
Countries
- Iran
Study Locations
Related Clinical Trials
-
Treatment of Failing Blebs With Ranibizumab
NCT00570726 · Status: COMPLETED · Phase: PHASE1
- Glaucoma, Open-Angle
- Failing Bleb Following Trabeculectomy
-
Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium
NCT01288404 · Status: COMPLETED · Phase: NA
- Pterygium of the Conjunctiva and Cornea
-
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy
NCT00468871 · Status: COMPLETED · Phase: PHASE2/PHASE3
- Non-infectious Uveitis
-
Treatment FOr Corticosteroid Dependent UveitiS
NCT06258915 · Status: NOT_YET_RECRUITING · Phase: PHASE3
- Non Infectious Uveitis
-
Lucentis Versus Mitomycin C During Glaucoma Surgery
NCT00626782 · Status: COMPLETED · Phase: PHASE2/PHASE3
- Glaucoma
More Related Trials
-
Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration
NCT00967213 ·Status: COMPLETED ·Phase: PHASE3
-
Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma
NCT00459849 ·Status: UNKNOWN ·Phase: NA
-
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
NCT02764697 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2 Study of MM-093 to Treat Patients With Uveitis
NCT00444743 ·Status: COMPLETED ·Phase: PHASE2
-
Methotrexate and Mycophenolate Mofetil for UVEITIS
NCT01829295 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy
NCT00679445 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye
NCT01531842 ·Status: UNKNOWN ·Phase: NA
-
Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.
NCT01942213 ·Status: COMPLETED
-
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
NCT02387957 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppressive Therapy
NCT06821971 ·Status: ACTIVE_NOT_RECRUITING
-
Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retinopathy
NCT06173245 ·Status: COMPLETED ·Phase: NA
-
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization
NCT00436553 ·Status: COMPLETED ·Phase: PHASE3
-
Sirolimus as Therapeutic Approach to Uveitis
NCT00908466 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy
NCT01944839 ·Status: TERMINATED ·Phase: PHASE3
-
A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy
NCT01940900 ·Status: TERMINATED ·Phase: PHASE3
-
Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
NCT01314417 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids
NCT00846625 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion
NCT01123564 ·Status: UNKNOWN ·Phase: PHASE2
-
Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia
NCT01968486 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal Haemangioma
NCT03571282 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy
NCT00540930 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV
NCT00429962 ·Status: COMPLETED ·Phase: PHASE3
-
Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis
NCT00804934 ·Status: COMPLETED
-
Effect of Ranibizumab on Malignant Conjunctival Neoplasia
NCT00456495 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy Study of Lucentis in the Treatment of Retinoblastoma
NCT01899066 ·Status: UNKNOWN ·Phase: PHASE2